Savannah News Online Reporting Only What Matters Most
Related Articles
MAY 10, 2024
President Biden Announces Key Appointments to Boards and Commissions
Washington, USA – Today, President Biden announced his intent to appoint Ghanaian American neurosurgeon Dr. Edjah Nduom and other individuals to serve in key roles.
They are:
Callisia N. Clarke, to be a Member of the National Cancer Advisory Board
Karen Emmons, to be a Member of the National Cancer Advisory Board
Tamika Felder, to be a Member of the National Cancer Advisory Board
Edjah K. Nduom, to be a Member of the National Cancer Advisory Board
Brian K. Bond, to be a Member of the President’s Commission on White House Fellowships
Nicole Isaac, to be a Member of the President’s Commission on
National Cancer Advisory Board
About The National Cancer Advisory Board
The National Cancer Advisory Board plays an important role in guiding the Director of the National Cancer Institute in setting the course for the national cancer research program. The National Cancer Advisory Board will complement the Cancer Moonshot, which President Biden reignited to end cancer as we know it – including by making sure his Administration is investing in research and development that will help advance breakthroughs to prevent, detect, and treat diseases like cancer.
Callisia N. Clarke, to be a Member of the National Cancer Advisory Board
Dr. Callisia Clarke completed her medical degree and general surgery residency at the University of Cincinnati College of Medicine, where she was elected to the Alpha Omega Alpha Honors Society. She then went on to complete a clinical and research fellowship in Complex General Surgical Oncology at The University of Texas MD Anderson Cancer Center. Clarke joined the faculty at the Medical College of Wisconsin in 2016 and is now an Associate Professor of Surgery and the Division Chief of Surgical Oncology. Her research efforts center on epigenetic regulation of pancreatic neuroendocrine tumors and surgical workforce diversification as a means to ameliorate cancer disparities. Clarke is nationally recognized and an expert in cancer disparities and management of gastroenteropancreatic neuroendocrine tumors. She holds several leadership positions in national organizations. Clarke is the President of the Association for Academic Surgery, the first Black woman to hold this office, and serves in other major leadership roles in the Society of Surgical Oncology and the American Board of Surgery.
Karen Emmons, to be a Member of the National Cancer Advisory Board
Karen Emmons is a Professor of Social and Behavioral Science at the Harvard T.H. Chan School of Public Health. She has expertise in cancer equity and in implementation science. Her work focuses on community-engaged approaches to implementation of cancer prevention interventions in settings that serve historically disadvantaged communities. She has more than 300 peer-reviewed publications and has served as PI for multiple National Institutes of Health-funded research projects and centers. She also serves as Faculty Director of the Community Engagement Program for Harvard’s Clinical Translational Science Award, Harvard Catalyst, which focuses on advancing evidence-based strategies to improve community health and creating bi-directional relationships between community partners and researchers. She serves as the MPI of Harvard Chan’s T32 training grant in cancer prevention and control and has received multiple mentoring awards. Her research has also been recognized by honors including the Morse Distinguished Researcher Award, Outstanding Senior Cancer Scientist Award from the Society of Behavioral Medicine, and Outstanding Scientist Award from the Society of Behavioral Medicine. She isPast-President of the Society of Behavioral Medicine, a member of the National Academy of Medicine, and a member of the Community Preventive Services Task Force.
Tamika Felder, to be a Member of the National Cancer Advisory Board
Tamika Felder founded Cervivor, Inc. in 2005 after surviving cervical cancer in her mid-twenties. As the non-profit’s Chief Visionary, she has been pivotal in dismantling the disease’s stigma. Through initiatives like the renowned Cervivor School, she has empowered ambassadors worldwide to speak out about cervical cancer.
Who is Dr. Nduom?
Dr. Edjah K. Nduom, MD, is the Daniel Louis Barrow Endowed Chair and Associate Professor in Neurosurgery at Emory University School of Medicine.
Additionally, he leads the Brain Tumors Disease Group at Winship Cancer Institute.
Nduom is renowned internationally for his contributions to the neurosurgical and brain tumor community, having founded the Society for Neuro-Oncology Sub-Saharan Africa and held roles such as Scientific Program Chair for the Congress of Neurological Surgeons Annual Meeting and Chair of the Board of Directors of the National Brain Tumor Society.
His research spans basic, translational, and clinical realms, with a focus on developing innovative immune therapy treatments for malignant brain tumors. Supported by grants from the National Institute of Neurological Disorders and Stroke (NINDS) and private foundations, Nduom has presented his work at numerous national and international conferences.
Nduom obtained his B.S. in Biomechanical Engineering from Stanford University in 2002 and his M.D. from the University of Pennsylvania in 2006. He completed Neurosurgical training at Emory University, including a Research Fellowship in Neurosurgical Oncology at the Surgical Neurology Branch of the NINDS. Following this, he pursued an additional Neurosurgical Oncology Fellowship at The University of Texas MD Anderson Cancer Center, where he was honored with the Jesse H. Jones Fellowship in Cancer Education. Before returning to Emory, Nduom served on the faculty of the Surgical Neurology Branch of the NINDS Intramural Research Program from 2015 to 2020.
By SavannahNewsOnline.Com/Philip Liebs
